New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Dyadic International Inc. (DYAI) vs Tvardi Therapeutics, Inc. (TVRD)
- Dyadic International Inc. DYAI 0.29 −6.45%
- Tvardi Therapeutics, Inc. TVRD 0.99 +4.21%
Dyadic International Inc. and Tvardi Therapeutics, Inc. are both Biotechnology companies. Dyadic International Inc. and Tvardi Therapeutics, Inc. are of similar size ($12.6M and $12.5M). Dyadic International Inc. grew revenue faster over the last twelve months: −7.64% against −55.3%. Dyadic International Inc. has the higher net margin (−226.9% vs −459.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Dyadic International Inc. leads on 8 and Tvardi Therapeutics, Inc. on 8.
Valuation
Profitability
| Metric | DYAI | TVRD | Biotechnology median |
|---|---|---|---|
| Gross margin | 17.85% | 146.85% | 70.18% |
| Operating margin | (237.12%) | (36.92%) | 0.00% |
| Net margin | (226.87%) | (459.31%) | 0.00% |
| Free cash flow margin | (227.93%) | 58.90% | 0.00% |
| Return on equity | (47,316.89%) | (123.08%) | (51.58%) |
| Return on assets | (71.43%) | (85.24%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack